BioLife Solutions, Inc. (BLFS) stock: analyst price target and their real reliability
Live quote · data updated Oct 14, 2026
BioLife Solutions, Inc. · Health Care · ref. ETF XLV · 53 calls · price $38.61
What the company does: BioLife Solutions, Inc. (BLFS) operates as a global provider of specialized bioproduction tools and services, primarily catering to the cell and gene therapy industry.
📈 BioLife Solutions, Inc. (BLFS) stock price
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Hold
0% recommend buying · 6 analysts
📊 JPI status : BioLife Solutions, Inc. has never appeared in a JPI ranking (Fair or Risk +) — our methods haven't picked it to date. See the selected stocks →
⚠️ The stock trades above the median target: it has beaten expectations. The “Hold” reflects conviction on the company, but the remaining quantified upside is low/negative.
🎯 BLFS price target & analyst consensus — price $38.61
The price target · all analysts combined (5 targets)
Highest target · 5 firms of 5$31-19.7%
Median target · of 5 targets$31-19.7%
Lowest target · 5 firms of 5$31-19.7%
Current price$38.61
Where these 5 targets sit · versus the current price · 1 target per firm, last 6 months
Below
5100%
$31
⭐ What the most reliable analysts say
· those who beat their sector, targets replayed on real prices
⭐ The most reliable of them, either direction: Jefferies — 61% of its targets hit on this sector (137 calls tested). It aims for $31 (-20 %), call made on July 24, 2026, maturing on July 24, 2027 (82 d ago).
The 3 reliable analysts
$31-20 %
The 2 other firms
$31-20 %
How to read it: the 3 reliable firms are not filtered by optimism — 0 aim above the price, 3 below, hence their $31 median. “The 2 others” are the firms that don't pass our reliability filter on this sector.
The consensus · 6 ratings (last 6 months)
Strong Buy00%
Buy00%
Hold6100%
Sell00%
Strong Sell00%
Go deeper on the analysts
🎯 BLFS price target all
All 53 calls, one by one, with our verdict on each firm.
→ See all 53 targets, analyst by analyst💡 The best analysts on BLFS most reliable
The case for and against, with the numbers, per those who've been right on the stock.
→ Should you invest in BLFS? The case for & againstAll analysts (the consensus) · vs · the best (those who've been right)
💬 A question about BioLife Solutions, Inc.? The JPI assistant answers using our backtest data.
🔎 Detailed analyses
🏛️ Which US Congress members hold BioLife Solutions, Inc. (BLFS)?
1 Congress member has disclosed BLFS buys. Click a highlighted name to see their track record (do they beat the S&P 500?).
Christopher Jacobs 1× · 21%
✅ Historical analyst reliability on BLFS
Hit rate measured on targets already matured (12 months), replayed against real prices. Click a header to sort.
| Firm ↕ | % right i ↕ | Gain vs sector i ↕ | Calls i ↕ |
|---|---|---|---|
| Maxim Group | 0% | 0.0% | 2 |
| B. Riley Securities ↗ | 0% | 0.0% | 4 |
| HC Wainwright & Co. ↗ | 0% | 0.0% | 8 |
| Northland Capital Markets ↗ | 0% | 0.0% | 3 |
| Oppenheimer ↗ | 0% | 0.0% | 3 |
| Benchmark ↗ | 0% | 0.0% | 4 |
| Lake Street | 0% | 0.0% | 2 |
| Keybanc ↗ | 0% | 0.0% | 5 |
| Stephens & Co. ↗ | 0% | 0.0% | 3 |
| Craig-Hallum ↗ | 0% | 0.0% | 4 |
📊 What $1,000 invested in BioLife Solutions, Inc. would be worth › open the full page
In short — $1,000 invested in BioLife Solutions, Inc. 10 years ago would be worth $13,203 today, i.e. +29%/yr on average. Best year: 2017 (+273%), worst: 2022 (-51%). Price performance, excluding dividends.
If I'd invested $1,000 in BioLife Solutions, Inc.
| Investment | Worth today | Gain |
|---|---|---|
| 1 years ago | $1,104 | +10% |
| 3 years ago | $1,574 | +57% |
| 5 years ago | $718 | -28% |
Return by year (BioLife Solutions, Inc.)
| Year | Return | $1,000 invested at year start |
|---|---|---|
| 2026 (YTD) | +18% | $1,185 (+18%) |
| 2025 | -7% | $1,104 (+10%) |
| 2024 | +60% | $1,763 (+76%) |
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.
📰 Recent news on BioLife Solutions, Inc.
Loading news…
📋 All analyst calls on BLFS
Filtered on — · ✕ show all
■ Hold neutral · not a buy
🎯 on BLFS : 0% (4 calls matureds) · 📊 on Health : 47.8% · +2.9% (69 calls)
in progress (365j)
matures : Aug 10, 27
matures : Aug 10, 27
Stephens & Co. ↗
Jul 27, 26
■ Equal-Weight neutral · not a buy · 🎯$31
Price at call : $38.61 — gap to target -20%
Today : $38.61 — gap to target -20%
🎯 on BLFS : 0% (3 calls matureds) · 📊 on Health : 44.3% · +2.1% (88 calls)
in progress (365j)
matures : Jul 27, 27
matures : Jul 27, 27
■ Hold neutral · not a buy · 🎯$31
Price at call : $38.61 — gap to target -20%
Today : $38.61 — gap to target -20%
🎯 on BLFS : 0% (1 call matured) · 📊 on Health : 49.6% · +9.4% (137 calls)
in progress (365j)
matures : Jul 23, 27
matures : Jul 23, 27
■ Hold neutral · not a buy · 🎯$31
Price at call : $38.61 — gap to target -20%
Today : $38.61 — gap to target -20%
🎯 on BLFS : 0% (3 calls matureds) · 📊 on Health : 50% · -1.0% (40 calls)
in progress (365j)
matures : Jul 23, 27
matures : Jul 23, 27
Lake Street
Jul 22, 26
■ Hold neutral · not a buy · 🎯$31
Price at call : $38.61 — gap to target -20%
Today : $38.61 — gap to target -20%
🎯 on BLFS : 0% (2 calls matureds) · 📊 on Health : 53.8% · +14.6% (26 calls)
in progress (365j)
matures : Jul 22, 27
matures : Jul 22, 27
HC Wainwright & Co. ↗
Jul 22, 26
■ Neutral neutral · not a buy · 🎯$31
Price at call : $38.61 — gap to target -20%
Today : $38.61 — gap to target -20%
🎯 on BLFS : 0% (8 calls matureds) · 📊 on Health : 57.4% · +25.1% (329 calls)
in progress (365j)
matures : Jul 22, 27
matures : Jul 22, 27
HC Wainwright & Co. ↗
Dec 29, 25
▲ Buy · 🎯$32
Price at call : $38.61 — upside -17%
Today : $38.61 — upside -17%
🎯 on BLFS : 0% (8 calls matureds) · 📊 on Health : 57.4% · +25.1% (329 calls)
in progress (365j)
matures : Dec 29, 26
matures : Dec 29, 26
HC Wainwright & Co. ↗
Nov 24, 25
▲ Buy · 🎯$32
Price at call : $38.61 — upside -17%
Today : $38.61 — upside -17%
🎯 on BLFS : 0% (8 calls matureds) · 📊 on Health : 57.4% · +25.1% (329 calls)
in progress (365j)
matures : Nov 24, 26
matures : Nov 24, 26
See the other 45 calls, newest to oldest
HC Wainwright & Co. ↗
Aug 8, 25
▲ Buy · 🎯$32
Price at call : $38.61 — upside -17%
Today : $38.61 — upside -17%
Expected -17% · Actual +0% · Reason (≥ +15%) : ✗ No
🎯 on BLFS : 0% (8 calls matureds) · 📊 on Health : 57.4% · +25.1% (329 calls)
0.0%
stock +0% · XLV +29%
matured Aug 8, 26
HC Wainwright & Co. ↗
May 13, 25
▲ Buy · 🎯$30
Price at call : $38.61 — upside -22%
Today : $38.61 — upside -22%
Expected -22% · Actual +0% · Reason (≥ +15%) : ✗ No
🎯 on BLFS : 0% (8 calls matureds) · 📊 on Health : 57.4% · +25.1% (329 calls)
0.0%
stock +0% · XLV +11%
matured May 13, 26
HC Wainwright & Co. ↗
Mar 6, 25
▲ Buy · 🎯$30
Price at call : $38.61 — upside -22%
Today : $38.61 — upside -22%
Expected -22% · Actual +0% · Reason (≥ +15%) : ✗ No
🎯 on BLFS : 0% (8 calls matureds) · 📊 on Health : 57.4% · +25.1% (329 calls)
0.0%
stock +0% · XLV +2%
matured Mar 6, 26
Northland Capital Markets ↗
Jan 8, 25
▲ Outperform · 🎯$31
Price at call : $38.61 — upside -20%
Today : $38.61 — upside -20%
Expected -20% · Actual +0% · Reason (≥ +15%) : ✗ No
🎯 on BLFS : 0% (3 calls matureds) · 📊 on Health : 23.1% · -19.9% (13 calls)
0.0%
stock +0% · XLV +13%
matured Jan 8, 26
▲ Buy · 🎯$30
Price at call : $38.61 — upside -22%
Today : $38.61 — upside -22%
Expected -22% · Actual +0% · Reason (≥ +15%) : ✗ No
🎯 on BLFS : 0% (4 calls matureds) · 📊 on Health : 47.8% · +2.9% (69 calls)
0.0%
stock +0% · XLV +14%
matured Dec 19, 25
▲ Overweight · 🎯$33
Price at call : $38.61 — upside -15%
Today : $38.61 — upside -15%
Expected -15% · Actual +0% · Reason (≥ +15%) : ✗ No
🎯 on BLFS : 0% (5 calls matureds) · 📊 on Health : 23.6% · -18.3% (110 calls)
0.0%
stock +0% · XLV +12%
matured Dec 13, 25
HC Wainwright & Co. ↗
Nov 18, 24
▲ Buy · 🎯$27
Price at call : $38.61 — upside -30%
Today : $38.61 — upside -30%
Expected -30% · Actual +0% · Reason (≥ +15%) : ✗ No
🎯 on BLFS : 0% (8 calls matureds) · 📊 on Health : 57.4% · +25.1% (329 calls)
0.0%
stock +0% · XLV +8%
matured Nov 18, 25
▲ Buy · 🎯$31
Price at call : $38.61 — upside -20%
Today : $38.61 — upside -20%
Expected -20% · Actual +0% · Reason (≥ +15%) : ✗ No
🎯 on BLFS : 0% (3 calls matureds) · 📊 on Health : 50% · -1.0% (40 calls)
0.0%
stock +0% · XLV +5%
matured Nov 13, 25
Craig-Hallum ↗
Nov 13, 24
▲ Buy · 🎯$32
Price at call : $38.61 — upside -17%
Today : $38.61 — upside -17%
Expected -17% · Actual +0% · Reason (≥ +15%) : ✗ No
🎯 on BLFS : 0% (4 calls matureds) · 📊 on Health : 52% · +14.5% (25 calls)
0.0%
stock +0% · XLV +5%
matured Nov 13, 25
HC Wainwright & Co. ↗
Sep 30, 24
▲ Buy · 🎯$29
Price at call : $38.61 — upside -25%
Today : $38.61 — upside -25%
Expected -25% · Actual +0% · Reason (≥ +15%) : ✗ No
🎯 on BLFS : 0% (8 calls matureds) · 📊 on Health : 57.4% · +25.1% (329 calls)
0.0%
stock +0% · XLV -10%
matured Sep 30, 25
Craig-Hallum ↗
Aug 12, 24
▲ Buy · 🎯$30
Price at call : $38.61 — upside -22%
Today : $38.61 — upside -22%
Expected -22% · Actual +0% · Reason (≥ +15%) : ✗ No
🎯 on BLFS : 0% (4 calls matureds) · 📊 on Health : 52% · +14.5% (25 calls)
0.0%
stock +0% · XLV -12%
matured Aug 12, 25
Northland Capital Markets ↗
Aug 9, 24
▲ Outperform · 🎯$28
Price at call : $38.61 — upside -27%
Today : $38.61 — upside -27%
Expected -27% · Actual +0% · Reason (≥ +15%) : ✗ No
🎯 on BLFS : 0% (3 calls matureds) · 📊 on Health : 23.1% · -19.9% (13 calls)
0.0%
stock +0% · XLV -13%
matured Aug 9, 25
▲ Buy · 🎯$26
Price at call : $38.61 — upside -33%
Today : $38.61 — upside -33%
Expected -33% · Actual +0% · Reason (≥ +15%) : ✗ No
🎯 on BLFS : 0% (3 calls matureds) · 📊 on Health : 50% · -1.0% (40 calls)
0.0%
stock +0% · XLV -10%
matured Jul 17, 25
▲ Buy · 🎯$25
Price at call : $38.61 — upside -35%
Today : $38.61 — upside -35%
Expected -35% · Actual +0% · Reason (≥ +15%) : ✗ No
🎯 on BLFS : 0% (4 calls matureds) · 📊 on Health : 47.8% · +2.9% (69 calls)
0.0%
stock +0% · XLV -8%
matured May 13, 25
▲ Buy · 🎯$22
Price at call : $38.61 — upside -43%
Today : $38.61 — upside -43%
Expected -43% · Actual +0% · Reason (≥ +15%) : ✗ No
🎯 on BLFS : 0% (1 call matured) · 📊 on Health : 49.6% · +9.4% (137 calls)
0.0%
stock +0% · XLV -5%
matured Apr 4, 25
Craig-Hallum ↗
Aug 10, 23
▲ Buy · 🎯$23
Price at call : $38.61 — upside -40%
Today : $38.61 — upside -40%
Expected -40% · Actual +0% · Reason (≥ +15%) : ✗ No
🎯 on BLFS : 0% (4 calls matureds) · 📊 on Health : 52% · +14.5% (25 calls)
0.0%
stock +0% · XLV +10%
matured Aug 9, 24
▲ Outperform · 🎯$25
Price at call : $38.61 — upside -35%
Today : $38.61 — upside -35%
Expected -35% · Actual +0% · Reason (≥ +15%) : ✗ No
🎯 on BLFS : 0% (3 calls matureds) · 📊 on Health : 50% · -1.0% (40 calls)
0.0%
stock +0% · XLV +11%
matured Aug 8, 24
Lake Street
Aug 9, 23
▲ Buy · 🎯$25
Price at call : $38.61 — upside -35%
Today : $38.61 — upside -35%
Expected -35% · Actual +0% · Reason (≥ +15%) : ✗ No
🎯 on BLFS : 0% (2 calls matureds) · 📊 on Health : 53.8% · +14.6% (26 calls)
0.0%
stock +0% · XLV +11%
matured Aug 8, 24
Stephens & Co. ↗
Jul 17, 23
▲ Overweight · 🎯$29
Price at call : $38.61 — upside -25%
Today : $38.61 — upside -25%
Expected -25% · Actual +0% · Reason (≥ +15%) : ✗ No
🎯 on BLFS : 0% (3 calls matureds) · 📊 on Health : 44.3% · +2.1% (88 calls)
0.0%
stock +0% · XLV +14%
matured Jul 16, 24
Craig-Hallum ↗
Jul 11, 23
▲ Buy · 🎯$29
Price at call : $38.61 — upside -25%
Today : $38.61 — upside -25%
Expected -25% · Actual +0% · Reason (≥ +15%) : ✗ No
🎯 on BLFS : 0% (4 calls matureds) · 📊 on Health : 52% · +14.5% (25 calls)
0.0%
stock +0% · XLV +13%
matured Jul 10, 24
Stephens & Co. ↗
Mar 17, 23
▲ Overweight · 🎯$27
Price at call : $38.61 — upside -30%
Today : $38.61 — upside -30%
Expected -30% · Actual +0% · Reason (≥ +15%) : ✗ No
🎯 on BLFS : 0% (3 calls matureds) · 📊 on Health : 44.3% · +2.1% (88 calls)
0.0%
stock +0% · XLV +15%
matured Mar 16, 24
Oppenheimer ↗
Mar 6, 23
▲ Outperform · 🎯$28
Price at call : $38.61 — upside -27%
Today : $38.61 — upside -27%
Expected -27% · Actual +0% · Reason (≥ +15%) : ✗ No
🎯 on BLFS : 0% (3 calls matureds) · 📊 on Health : 47.4% · +5.9% (95 calls)
0.0%
stock +0% · XLV +12%
matured Mar 5, 24
Stephens & Co. ↗
May 10, 22
▲ Overweight · 🎯$40
Price at call : $38.61 — upside +4%
Today : $38.61 — upside +4%
Expected +4% · Actual +0% · Reason (≥ +15%) : ✗ No
🎯 on BLFS : 0% (3 calls matureds) · 📊 on Health : 44.3% · +2.1% (88 calls)
0.0%
stock +0% · XLV +5%
matured May 10, 23
▲ Overweight · 🎯$30
Price at call : $38.61 — upside -22%
Today : $38.61 — upside -22%
Expected -22% · Actual +0% · Reason (≥ +15%) : ✗ No
🎯 on BLFS : 0% (5 calls matureds) · 📊 on Health : 23.6% · -18.3% (110 calls)
0.0%
stock +0% · XLV +5%
matured May 10, 23
Oppenheimer ↗
Apr 25, 22
▲ Outperform · 🎯$28
Price at call : $38.61 — upside -27%
Today : $38.61 — upside -27%
Expected -27% · Actual +0% · Reason (≥ +15%) : ✗ No
🎯 on BLFS : 0% (3 calls matureds) · 📊 on Health : 47.4% · +5.9% (95 calls)
0.0%
stock +0% · XLV -1%
matured Apr 25, 23
▲ Overweight · 🎯$60
Price at call : $38.61 — upside +55%
Today : $38.61 — upside +55%
Expected +55% · Actual +0% · Reason (≥ +15%) : ✗ No
🎯 on BLFS : 0% (5 calls matureds) · 📊 on Health : 23.6% · -18.3% (110 calls)
0.0%
stock +0% · XLV +0%
matured Aug 13, 22
■ Hold neutral · not a buy
🎯 on BLFS : 0% (4 calls matureds) · 📊 on Health : 47.8% · +2.9% (69 calls)
in progress (365j)
matures : May 14, 22
matures : May 14, 22
▲ Buy · 🎯$54
Price at call : $38.61 — upside +40%
Today : $38.61 — upside +40%
Expected +40% · Actual +0% · Reason (≥ +15%) : ✗ No
🎯 on BLFS : 0% (4 calls matureds) · 📊 on Health : 47.8% · +2.9% (69 calls)
0.0%
stock +0% · XLV +17%
matured Mar 23, 22
▲ Overweight · 🎯$50
Price at call : $38.61 — upside +30%
Today : $38.61 — upside +30%
Expected +30% · Actual +0% · Reason (≥ +15%) : ✗ No
🎯 on BLFS : 0% (5 calls matureds) · 📊 on Health : 23.6% · -18.3% (110 calls)
0.0%
stock +0% · XLV +17%
matured Mar 23, 22
▲ Overweight · 🎯$40
Price at call : $38.61 — upside +4%
Today : $38.61 — upside +4%
Expected +4% · Actual +0% · Reason (≥ +15%) : ✗ No
🎯 on BLFS : 0% (5 calls matureds) · 📊 on Health : 23.6% · -18.3% (110 calls)
0.0%
stock +0% · XLV +20%
matured Nov 10, 21
Oppenheimer ↗
Sep 22, 20
■ Perform neutral · not a buy
🎯 on BLFS : 0% (3 calls matureds) · 📊 on Health : 47.4% · +5.9% (95 calls)
in progress (365j)
matures : Sep 22, 21
matures : Sep 22, 21
Cowen & Co.
Sep 18, 20
▲ Outperform · 🎯$33
Price at call : $38.61 — upside -15%
Today : $38.61 — upside -15%
Expected -15% · Actual +0% · Reason (≥ +15%) : ✗ No
🎯 on BLFS : 0% (1 call matured) · 📊 unranked overall
0.0%
stock +0% · XLV +24%
matured Sep 18, 21
■ Hold neutral · not a buy
🎯 on BLFS : 0% (4 calls matureds) · 📊 on Health : 47.8% · +2.9% (69 calls)
in progress (365j)
matures : Aug 11, 21
matures : Aug 11, 21
B. Riley Securities ↗
May 4, 20
▲ Buy · 🎯$22
Price at call : $38.61 — upside -43%
Today : $38.61 — upside -43%
Expected -43% · Actual +0% · Reason (≥ +15%) : ✗ No
🎯 on BLFS : 0% (3 calls matureds) · 📊 on Health : 41.7% · +17.4% (36 calls)
0.0%
stock +0% · XLV +26%
matured May 4, 21
HC Wainwright & Co. ↗
Mar 23, 20
▲ Buy · 🎯$17
Price at call : $38.61 — upside -56%
Today : $38.61 — upside -56%
Expected -56% · Actual +0% · Reason (≥ +15%) : ✗ No
🎯 on BLFS : 0% (8 calls matureds) · 📊 on Health : 57.4% · +25.1% (329 calls)
0.0%
stock +0% · XLV +42%
matured Mar 23, 21
B. Riley Securities ↗
Mar 12, 20
▲ Buy · 🎯$24
Price at call : $38.61 — upside -38%
Today : $38.61 — upside -38%
Expected -38% · Actual +0% · Reason (≥ +15%) : ✗ No
🎯 on BLFS : 0% (3 calls matureds) · 📊 on Health : 41.7% · +17.4% (36 calls)
0.0%
stock +0% · XLV +35%
matured Mar 12, 21
Lake Street
Feb 24, 20
▲ Buy · 🎯$25
Price at call : $38.61 — upside -35%
Today : $38.61 — upside -35%
Expected -35% · Actual +0% · Reason (≥ +15%) : ✗ No
🎯 on BLFS : 0% (2 calls matureds) · 📊 on Health : 53.8% · +14.6% (26 calls)
0.0%
stock +0% · XLV +18%
matured Feb 23, 21
▲ Buy · 🎯$24
Price at call : $38.61 — upside -38%
Today : $38.61 — upside -38%
Expected -38% · Actual +0% · Reason (≥ +15%) : ✗ No
🎯 on BLFS : 0% (4 calls matureds) · 📊 on Health : 47.8% · +2.9% (69 calls)
0.0%
stock +0% · XLV +11%
matured Feb 18, 21
B. Riley Securities ↗
Feb 6, 20
▲ Buy · 🎯$27
Price at call : $38.61 — upside -30%
Today : $38.61 — upside -30%
Expected -30% · Actual +0% · Reason (≥ +15%) : ✗ No
🎯 on BLFS : 0% (3 calls matureds) · 📊 on Health : 41.7% · +17.4% (36 calls)
0.0%
stock +0% · XLV +11%
matured Feb 5, 21
HC Wainwright & Co. ↗
Dec 16, 19
▲ Buy · 🎯$26
Price at call : $38.61 — upside -33%
Today : $38.61 — upside -33%
Expected -33% · Actual +0% · Reason (≥ +15%) : ✗ No
🎯 on BLFS : 0% (8 calls matureds) · 📊 on Health : 57.4% · +25.1% (329 calls)
0.0%
stock +0% · XLV +10%
matured Dec 15, 20
Oppenheimer ↗
Nov 21, 19
▲ Outperform · 🎯$22
Price at call : $38.61 — upside -43%
Today : $38.61 — upside -43%
Expected -43% · Actual +0% · Reason (≥ +15%) : ✗ No
🎯 on BLFS : 0% (3 calls matureds) · 📊 on Health : 47.4% · +5.9% (95 calls)
0.0%
stock +0% · XLV +11%
matured Nov 20, 20
Northland Capital Markets ↗
Sep 4, 19
▲ Outperform · 🎯$22
Price at call : $38.61 — upside -43%
Today : $38.61 — upside -43%
Expected -43% · Actual +0% · Reason (≥ +15%) : ✗ No
🎯 on BLFS : 0% (3 calls matureds) · 📊 on Health : 23.1% · -19.9% (13 calls)
0.0%
stock +0% · XLV +18%
matured Sep 3, 20
HC Wainwright & Co. ↗
Jul 22, 19
▲ Buy · 🎯$23
Price at call : $38.61 — upside -40%
Today : $38.61 — upside -40%
Expected -40% · Actual +0% · Reason (≥ +15%) : ✗ No
🎯 on BLFS : 0% (8 calls matureds) · 📊 on Health : 57.4% · +25.1% (329 calls)
0.0%
stock +0% · XLV +16%
matured Jul 21, 20
Maxim Group
May 11, 18
▲ Buy · 🎯$12
Price at call : $38.61 — upside -69%
Today : $38.61 — upside -69%
Expected -69% · Actual +0% · Reason (≥ +15%) : ✗ No
🎯 on BLFS : 0% (2 calls matureds) · 📊 on Health : 0% · -27.9% (5 calls)
0.0%
stock +0% · XLV +4%
matured May 11, 19
Maxim Group
Nov 10, 17
▲ Buy · 🎯$8
Price at call : $38.61 — upside -79%
Today : $38.61 — upside -79%
Expected -79% · Actual +0% · Reason (≥ +15%) : ✗ No
🎯 on BLFS : 0% (2 calls matureds) · 📊 on Health : 0% · -27.9% (5 calls)
0.0%
stock +0% · XLV +13%
matured Nov 10, 18
Frequently asked questions
Should I buy BioLife Solutions, Inc. stock?
This isn't buy advice. For BioLife Solutions, Inc., the analyst consensus is "Hold", with an average price target of $31.00 (-20% vs the current price). What matters is their past reliability on this stock: the most reliable one is right 0% of the time (2 calls tracked on BioLife Solutions, Inc.). We show the numbers — you decide.
Is it too late to buy BioLife Solutions, Inc.? How high can it go?
The most bullish analyst target on BioLife Solutions, Inc. is $31.00 (-20% above today's price); the average is $31.00. That's the upside they see. Check how reliable those analysts have actually been on BioLife Solutions, Inc. on our site before trusting it.
Is BioLife Solutions, Inc. still a good buy?
The most useful "opinion" isn't an opinion — it's a track record: 11 analysts have a real record on BioLife Solutions, Inc., the best hitting 0% over 2 calls. Current consensus: "Hold". Make your call on data, not noise.
Should you invest in BioLife Solutions, Inc.? The case for and against
The arguments for and against, one by one, from the numbers: why invest in BLFS (and why hesitate).
What has BioLife Solutions, Inc.'s past performance been?
Historical returns and a "how much if I had invested" calculator: BLFS performance & returns.
BIIB 
VRTX 
REGN 
UNH 
EW 
SRPT 
VEEV 
BSX